Gwenn Waerlop

发表

Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine

G. Leroux-Roels, P. Moris, I. Leroux-Roels, 2022, Frontiers in Immunology.

The role of cell-mediated immunity against influenza and its implications for vaccine evaluation

G. Leroux-Roels, Yorick Janssens, I. Leroux-Roels, 2022, Frontiers in Immunology.

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2

N. Klopp, P. Kremsner, M. Fotin‐Mleczek, 2021, Wiener klinische Wochenschrift.

A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine

G. Leroux-Roels, Yorick Janssens, F. Thieme, 2022, Frontiers in Immunology.

Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium

R. Cox, G. Leroux-Roels, E. Gianchecchi, 2022, Frontiers in Immunology.

Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4+ T cell immunity within the FLUCOP consortium

R. Cox, G. Leroux-Roels, E. Gianchecchi, 2022, Frontiers in Immunology.

Immune responses in healthy adults elicited by a bivalent norovirus vaccine candidate composed of GI.4 and GII.4 VLPs without adjuvant

G. Leroux-Roels, Yorick Janssens, F. Thieme, 2023, Frontiers in Immunology.

Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate: a randomised, double-blind, placebo-controlled, phase 2a trial.

G. Leroux-Roels, Yorick Janssens, I. Leroux-Roels, 2023, The Lancet. Infectious diseases.

Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial

G. Rimmelzwaan, G. Leroux-Roels, I. Leroux-Roels, 2024, The Lancet Infectious Diseases.